Page last updated: 2024-11-05

zolpidem and Pyrosis

zolpidem has been researched along with Pyrosis in 1 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research Excerpts

ExcerptRelevanceReference
"Symptom assessments using GerdQ and reflux monitoring were performed before and after a 28-day treatment with 5 mg lemborexant at bedtime."3.30Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia: A Single-Arm Proof-of-Concept Study. ( Hoshikawa, Y; Iwakiri, K; Kawami, N; Momma, E, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hoshikawa, Y1
Momma, E1
Kawami, N1
Iwakiri, K1

Trials

1 trial available for zolpidem and Pyrosis

ArticleYear
Lemborexant Attenuates Regurgitation without Worsening Objective Parameters on Reflux Monitoring in Patients with Gastroesophageal Reflux Disease and Insomnia: A Single-Arm Proof-of-Concept Study.
    Digestion, 2023, Volume: 104, Issue:6

    Topics: Esophageal pH Monitoring; Female; Gastroesophageal Reflux; Heartburn; Humans; Hypnotics and Sedative

2023